{"id":"https://openalex.org/W7223398944","doi":"https://doi.org/10.3389/fphar.2026.1977895","title":"Engineered hyalurosomal gel co-delivering citicoline sodium and nifedipine for potential glaucoma management: formulation and pharmacodynamic evaluation","display_name":"Engineered hyalurosomal gel co-delivering citicoline sodium and nifedipine for potential glaucoma management: formulation and pharmacodynamic evaluation","publication_year":2026,"publication_date":"2026-10-23","ids":{"openalex":"https://openalex.org/W7223398944","doi":"https://doi.org/10.3389/fphar.2026.1977895"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1977895","doi":"https://doi.org/10.3389/fphar.2026.1977895","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1977895","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1977895/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1977895/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084216498","display_name":"Doaa Hegazy","orcid":"https://orcid.org/0000-0001-7218-1056","observed_orcids":["https://orcid.org/0000-0001-7218-1056"]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":true,"raw_author_name":"Doaa Hegazy","raw_affiliation_strings":["Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057625622","display_name":"Mennatullah M. Ibrahim","orcid":"https://orcid.org/0000-0002-2069-5853","observed_orcids":["https://orcid.org/0000-0002-2069-5853"]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mennatullah M. Ibrahim","raw_affiliation_strings":["Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060358836","display_name":"Riham A. El\u2010Shiekh","orcid":"https://orcid.org/0000-0002-3179-3352","observed_orcids":["https://orcid.org/0000-0002-3179-3352"]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Riham A. El-Shiekh","raw_affiliation_strings":["Department of Pharmacognosy, Faculty of Pharmacy, Cairo University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacognosy, Faculty of Pharmacy, Cairo University","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042257883","display_name":"Osama Saher","orcid":"https://orcid.org/0000-0003-3286-5706","observed_orcids":["https://orcid.org/0000-0003-3286-5706"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["EG","SE"],"is_corresponding":true,"raw_author_name":"Osama Saher","raw_affiliation_strings":["Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge and Karolinska Comprehensive Cancer Center","Department of Laboratory Medicine, Karolinska Institute","Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge and Karolinska Comprehensive Cancer Center","institution_ids":["https://openalex.org/I1335113835"]},{"raw_affiliation_string":"Department of Laboratory Medicine, Karolinska Institute","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102650948","display_name":"Nouran A. Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Nouran A. Ali","raw_affiliation_strings":["Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University","institution_ids":["https://openalex.org/I145487455"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5042257883","https://openalex.org/A5084216498"],"corresponding_institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I145487455","https://openalex.org/I28166907"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":3.0368,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.92951469,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10343","display_name":"Hydrogels: synthesis, properties, applications","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.9190000295639038},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.921999990940094},{"id":"https://openalex.org/keywords/topical-ocular-drug-delivery","display_name":"topical ocular drug delivery","score":0.6660000085830688},{"id":"https://openalex.org/keywords/hydrogel-formulation","display_name":"hydrogel formulation","score":0.656000018119812},{"id":"https://openalex.org/keywords/intraocular-pressure-reduction","display_name":"intraocular pressure reduction","score":0.7730000019073486},{"id":"https://openalex.org/keywords/retinal-ganglion-cell-neuroprotection","display_name":"retinal ganglion cell neuroprotection","score":0.8550000190734863},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.765999972820282},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.7419999837875366},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.5809999704360962},{"id":"https://openalex.org/keywords/ocular-pharmacokinetics","display_name":"ocular pharmacokinetics","score":0.621999979019165},{"id":"https://openalex.org/keywords/free-radical-scavenging-activity","display_name":"free radical scavenging","score":0.7329999804496765},{"id":"https://openalex.org/keywords/ocular-toxicity","display_name":"ocular toxicity","score":0.3490000069141388}],"concepts":[{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.6104000210762024},{"id":"https://openalex.org/C2780496003","wikidata":"https://www.wikidata.org/wiki/Q28529682","display_name":"Citicoline","level":2,"score":0.5799000263214111},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5598999857902527},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5454000234603882},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.5224999785423279},{"id":"https://openalex.org/C2776521421","wikidata":"https://www.wikidata.org/wiki/Q9294051","display_name":"Ocular hypertension","level":3,"score":0.45179998874664307},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4262000024318695},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.40880000591278076},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.36239999532699585},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.34119999408721924},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.320499986410141},{"id":"https://openalex.org/C2779066535","wikidata":"https://www.wikidata.org/wiki/Q39111","display_name":"Nifedipine","level":3,"score":0.3003999888896942},{"id":"https://openalex.org/C538909803","wikidata":"https://www.wikidata.org/wiki/Q116907","display_name":"Glutathione","level":3,"score":0.2955000102519989},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.2948000133037567},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.27239999175071716},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.2703999876976013},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.27000001072883606},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2623000144958496},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.259799987077713},{"id":"https://openalex.org/C120770815","wikidata":"https://www.wikidata.org/wiki/Q14859627","display_name":"Vasodilation","level":2,"score":0.2524000108242035}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fphar.2026.1977895","doi":"https://doi.org/10.3389/fphar.2026.1977895","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1977895","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1977895/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:5e3df508372844828384c47120295678","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5e3df508372844828384c47120295678","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1977895","doi":"https://doi.org/10.3389/fphar.2026.1977895","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1977895","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1977895/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223398944.pdf","grobid_xml":"https://content.openalex.org/works/W7223398944.grobid-xml"},"referenced_works_count":109,"referenced_works":["https://openalex.org/W129305155","https://openalex.org/W1745951729","https://openalex.org/W1844725082","https://openalex.org/W1964908577","https://openalex.org/W1969578574","https://openalex.org/W1977784832","https://openalex.org/W1994856188","https://openalex.org/W2001052482","https://openalex.org/W2010190028","https://openalex.org/W2028416533","https://openalex.org/W2034729671","https://openalex.org/W2063630403","https://openalex.org/W2071636590","https://openalex.org/W2074417814","https://openalex.org/W2087489017","https://openalex.org/W2087496871","https://openalex.org/W2088222110","https://openalex.org/W2101774639","https://openalex.org/W2205810849","https://openalex.org/W2311902495","https://openalex.org/W2322214985","https://openalex.org/W2529643657","https://openalex.org/W2545660909","https://openalex.org/W2553653454","https://openalex.org/W2601896599","https://openalex.org/W2753400916","https://openalex.org/W2763539192","https://openalex.org/W2773035170","https://openalex.org/W2782690276","https://openalex.org/W2792003752","https://openalex.org/W2799323928","https://openalex.org/W2804846127","https://openalex.org/W2807203217","https://openalex.org/W2889537279","https://openalex.org/W2911194996","https://openalex.org/W2913887360","https://openalex.org/W2923683328","https://openalex.org/W2946283160","https://openalex.org/W2981208084","https://openalex.org/W2984594547","https://openalex.org/W2985597848","https://openalex.org/W2997068572","https://openalex.org/W2998793105","https://openalex.org/W3004994098","https://openalex.org/W3005333161","https://openalex.org/W3011008131","https://openalex.org/W3014529144","https://openalex.org/W3036046130","https://openalex.org/W3135251242","https://openalex.org/W3136216771","https://openalex.org/W3161413659","https://openalex.org/W3191639090","https://openalex.org/W3192999754","https://openalex.org/W3194402636","https://openalex.org/W3215018239","https://openalex.org/W3215275457","https://openalex.org/W4205142586","https://openalex.org/W4210630459","https://openalex.org/W4229064091","https://openalex.org/W4285733349","https://openalex.org/W4291512917","https://openalex.org/W4313379438","https://openalex.org/W4315487413","https://openalex.org/W4319058770","https://openalex.org/W4323313218","https://openalex.org/W4376620042","https://openalex.org/W4377029988","https://openalex.org/W4386026910","https://openalex.org/W4386934726","https://openalex.org/W4389088361","https://openalex.org/W4389275256","https://openalex.org/W4392614323","https://openalex.org/W4393045816","https://openalex.org/W4393935186","https://openalex.org/W4400438881","https://openalex.org/W4403806670","https://openalex.org/W4408554992","https://openalex.org/W4409252640","https://openalex.org/W4409459232","https://openalex.org/W4411255826","https://openalex.org/W4412437738","https://openalex.org/W4412828015","https://openalex.org/W4413927282","https://openalex.org/W4414007516","https://openalex.org/W4414036538","https://openalex.org/W4415524897","https://openalex.org/W4415710985","https://openalex.org/W4415717771","https://openalex.org/W4416147529","https://openalex.org/W4416291290","https://openalex.org/W4416456476","https://openalex.org/W4416856305","https://openalex.org/W4416904121","https://openalex.org/W7092368790","https://openalex.org/W7124418731","https://openalex.org/W7125975474","https://openalex.org/W7125985732","https://openalex.org/W7128592302","https://openalex.org/W7130472856","https://openalex.org/W7139097853","https://openalex.org/W7140396773","https://openalex.org/W7143381512","https://openalex.org/W7143461470","https://openalex.org/W7154489478","https://openalex.org/W7160907441","https://openalex.org/W7163377278","https://openalex.org/W7169796916","https://openalex.org/W7203922112","https://openalex.org/W7204457766"],"related_works":["https://openalex.org/W4415447461","https://openalex.org/W3191639090","https://openalex.org/W7124704748","https://openalex.org/W4412521889","https://openalex.org/W7154879370","https://openalex.org/W4411358392","https://openalex.org/W2585734108","https://openalex.org/W6926645813","https://openalex.org/W3036607539","https://openalex.org/W2994862233"],"abstract_inverted_index":{"Introduction":[0],"Glaucoma":[1],"is":[2],"a":[3,37,52,59,79,196,217,296],"neurodegenerative":[4],"ocular":[5,43,151,279,287],"disorder":[6],"that":[7,41],"requires":[8],"multi-targeted":[9],"therapeutic":[10,62,299],"strategies":[11],"to":[12,184,246],"counteract":[13],"intraocular":[14],"pressure":[15],"(IOP)":[16],"elevation":[17],"and":[18,45,48,55,75,91,98,116,136,156,165,189,234,270,274,290],"oxidative":[19],"stress\u2013mediated":[20],"retinal":[21],"ganglion":[22],"cells":[23],"(RGCs)":[24],"loss.":[25],"This":[26],"study":[27],"developed":[28],"an":[29,94,149],"innovative":[30],"hyalurosomal":[31],"hydrogel":[32],"platform":[33],"co-delivering":[34],"Nifedipine":[35],"(NFD,":[36],"calcium":[38],"channel":[39],"blocker":[40],"promotes":[42],"vasodilation":[44],"IOP":[46,221,255],"reduction)":[47],"Citicoline":[49],"sodium":[50],"(CTC,":[51],"potent":[53],"neuroprotective":[54],"antioxidant":[56],"agent)":[57],"as":[58,295],"potential":[60,119,294],"topical":[61,298],"approach":[63,300],"for":[64,163,167,301],"glaucoma.":[65,302],"Methods":[66],"NFD-loaded":[67],"hyalurosomes":[68],"(NFD-HAs)":[69],"were":[70],"prepared":[71],"using":[72],"thin-film":[73],"hydration":[74],"statistically":[76],"optimized":[77,83],"via":[78],"D-Optimal":[80],"design.":[81],"The":[82,141,169],"formulation":[84],"(NFD-OF)":[85],"was":[86],"probe-sonicated,":[87],"combined":[88],"with":[89,206],"CTC,":[90],"incorporated":[92],"into":[93],"HPMC":[95],"hydrogel.":[96],"Results":[97],"discussion":[99],"Sonicated":[100],"NFD-OF":[101],"displayed":[102],"nanosized":[103],"spherical":[104,132],"vesicles":[105],"(198.6":[106],"\u00b1":[107,114,121,154,224,231,243,252,262],"23.1":[108],"nm),":[109],"high":[110],"entrapment":[111],"efficiency":[112],"(70.7":[113],"1.8%),":[115],"stable":[117],"zeta":[118],"(\u201339.1":[120],"1.3":[122],"mV).":[123],"Transmission":[124],"electron":[125],"microscopy":[126,194],"(TEM)":[127],"analysis":[128],"confirmed":[129,195,277],"the":[130,207,282],"distinct":[131],"morphology,":[133],"non-aggregated":[134],"state,":[135],"structural":[137],"integrity":[138],"of":[139],"NFD-OF.":[140],"final":[142],"CTC/NFD-OF":[143,283],"gel":[144,171,284],"exhibited":[145],"pseudoplastic":[146],"shear-thinning":[147],"flow,":[148],"optimal":[150],"pH":[152],"(6.9":[153],"0.02),":[155],"sustained":[157],"release":[158,271],"over":[159],"24":[160],"h":[161],"(65.5%":[162],"NFD":[164,186],"99.5%":[166],"CTC).":[168],"dual":[170],"demonstrated":[172,285],"superior":[173],"free":[174,185],"radical":[175],"scavenging":[176],"capability":[177],"(IC":[178],"50":[179],"=":[180,241,260],"16.44\u00b10.7":[181],"\u03bcg/mL)":[182,188],"compared":[183,205,245],"(219.43":[187],"CTC":[190],"(234.62":[191],"\u03bcg/mL).":[192],"Confocal":[193],"2.2-fold":[197],"enhancement":[198],"in":[199],"transcorneal":[200],"penetration":[201],"depth":[202],"(110":[203],"\u03bcm)":[204],"control":[208],"solution":[209],"(50":[210],"\u03bcm).":[211],"In":[212],"vivo":[213],"pharmacodynamic":[214],"evaluation":[215],"revealed":[216],"significantly":[218],"higher":[219],"maximum":[220],"decrease":[222],"(51.85":[223],"8.2%),":[225],"extended":[226],"mean":[227],"residence":[228],"time":[229],"(8.9":[230],"2.7":[232],"h),":[233],"increased":[235],"relative":[236],"exposure":[237],"(AUC":[238],"0":[239,258],"\u2013\u221e":[240,259],"494.1":[242],"191.9)":[244],"commercial":[247],"Xola\u2122":[248],"eye":[249],"drops":[250],"(36.4":[251],"5.9%":[253],"max":[254],"decrease,":[256],"AUC":[257],"182.8":[261],"33.7).":[263],"Terminal":[264],"gamma":[265],"sterilization":[266],"preserved":[267],"physicochemical":[268],"characteristics":[269],"profiles.":[272],"Draize":[273],"histopathological":[275],"assays":[276],"excellent":[278],"tolerability.":[280],"Overall,":[281],"promising":[286],"hypotensive":[288],"activity":[289],"safety,":[291],"supporting":[292],"its":[293],"multifunctional":[297]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-10-24T00:00:00"}